Skip to main content
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (IST:GENIL)
Turkey flag Turkey · Delayed Price · Currency is TRY
146.20
+2.40 (1.67%)
Last updated: Apr 4, 2025

IST:GENIL Revenue

In the year 2024, Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi had annual revenue of 14.74B TRY with 25.25% growth. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi had revenue of 3.87B in the quarter ending December 31, 2024, a decrease of -2.24%.

Revenue
14.74B
Revenue Growth
+25.25%
P/S Ratio
2.97
Revenue / Employee
23.81M
Employees
619
Market Cap
43.71B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202414.74B2.97B25.25%
Dec 31, 202311.77B1.13B10.62%
Dec 31, 202210.64B8.14B325.34%
Dec 31, 20212.50B351.38M16.34%
Dec 31, 20202.15B354.82M19.77%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MLP Saglik Hizmetleri A.S. 39.69B
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. 128.62B
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. 8.77B
Deva Holding A.S. 15.46B
Tapdi Oksijen Özel Saglik ve Egitim Hizmetleri Sanayi Ticaret A.S. 2.19B
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi 2.09B
Lokman Hekim Engürüsag Saglik, Turizm, Egitim Hizmetleri ve Insaat Taahhüt A.S. 2.94B
Turk Ilac Ve Serum Sanayi Anonim Sirketi 2.57B
Revenue Rankings